Voluntary Health Deals Without Teeth: How the Trump Administration's Headline-Grabbing Agreements Are Quietly Falling Apart

There's a particular kind of political magic in the photo op: gather some kids, some concerned mothers, a charismatic leader, and announce a victory for the people. The standing ovation feels real. The commitment sounds solid. Then nothing happens.

That's the story CBS News reports about the Trump administration's health industry deals, the ones that HHS Secretary Robert F. Kennedy Jr. has been trumpeting since April 2025. The deals look impressive on paper: removing synthetic dyes from food and drugs, lowering drug prices, adding nutrition classes to medical education. These are popular ideas. A Consumer Reports survey found 72% of Americans concerned about synthetic dyes in food; two-thirds thought companies should be required to remove them.

But here's the problem. These aren't regulations. They're voluntary pledges with no enforcement mechanism, no real deadline, and no public accountability.

The Dyes Announcement: Declared Victory Before Delivery

Take the synthetic dyes deal. In April 2025, Kennedy announced that companies had pledged to phase out nine petroleum-based synthetic dyes from the nation's food supply by the end of 2025. The HHS stage was full of young children and mothers holding signs reading "Make America Healthy Again." Kennedy and former FDA Commissioner Marty Makary got a standing ovation.

Kennedy came back a year later, at the Conservative Political Action Conference in 2026, and declared: "We've gotten rid of the nine synthetic-based food dyes."

Not really.

The FDA quietly moved the deadline from the end of 2025 to the end of 2027. Most of the dyes are still in use. Doritos and Kellogg's Froot Loops still contain them. Only 27 companies had made pledges as of December 2025. There's no enforcement mechanism. There's no penalty for missing the new deadline. There's no public dashboard tracking which companies are actually complying and which aren't.

This matters because voluntary agreements create an illusion of action while leaving the actual problem unsolved. They're a substitute for real policy, the kind with teeth, with timelines, with consequences.

Why This Approach Fails Health Policy

The administration chose voluntary deals because they fit an anti-regulatory ideology and let officials claim quick wins ahead of elections. It's a strategy, not a solution. But health policy isn't theater. It's about whether your grandmother can afford her insulin, whether your kids are exposed to harmful chemicals, whether you can trust that the food system is working for your family's health instead of against it.

Voluntary deals don't deliver on any of that. Without enforcement, companies have no incentive to change. Without timelines with teeth, deadlines slip. Without transparency, the public can't see what's actually happening. And without oversight, administrators can declare victory whether or not anything changed.

Larry Levitt, executive vice president for health policy at KFF, told CBS: "These deals are often not transparent, so there's no way for the public to judge how meaningful they are." That's the core problem. You can't hold a system accountable if you can't see it working.

The Larger Pattern

This isn't one isolated deal. According to the reporting, many of the administration's highest-profile health initiatives rely on these voluntary agreements. They lack oversight. Their details are vague. The administration has claimed victories that haven't materialized. And when the political attention fades, so do the promises.

Real change in health policy requires real enforcement. It requires clear timelines. It requires penalties for non-compliance and rewards for success. It requires transparency so voters, patients, and regulators can actually see what's happening. And it requires the political will to regulate when markets alone won't protect people's health.